HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia

scientific article published on 15 May 2019

HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/IJC.32383
P698PubMed publication ID31044428

P50authorFrancesco PiazzaQ42361968
Andrea VisentinQ47162957
Livio TrentinQ56383785
Federica FrezzatoQ57119101
Filippo SeverinQ85696297
P2093author name stringGiuseppe Basso
Monica Facco
Gianpietro Semenzato
Benedetta Accordi
Silvia Bresolin
Valentina Trimarco
Veronica Martini
Edoardo Scomazzon
Flavia Raggi
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectchronic lymphocytic leukemiaQ1088156
P1104number of pages12
P304page(s)3089-3100
P577publication date2019-05-15
P1433published inInternational Journal of CancerQ332492
P1476titleHSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia
P478volume145

Reverse relations

cites work (P2860)
Q91809783In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment
Q100750299In vitro maturation in the presence of Leukemia Inhibitory Factor modulates gene and miRNA expression in bovine oocytes and embryos
Q97419293Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression
Q92539620miR-30b-3p Inhibits Proliferation and Invasion of Hepatocellular Carcinoma Cells via Suppressing PI3K/Akt Pathway